'Drug psychoactivity' presentation slideshows

Newly developed compounds limit psychoactivity and cognitive impairment and may be especially useful for pediatric appli

Vitality Biopharma, Inc. a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it has created a library of proprietary glycosides of THC, the main psychoactive chemical found in cannabis or marijuana, which enable targeted delivery that reduces or eliminates psychoactivity when used in oral drug formulations.

145 views • 8 slides